Follow
Mark Avigan
Mark Avigan
Associate Office Director, FDA & Professor (Adjunct), Georgetown U. School of Medicine
Verified email at fda.hhs.gov
Title
Cited by
Cited by
Year
Case definition and phenotype standardization in drug‐induced liver injury
GP Aithal, PB Watkins, RJ Andrade, D Larrey, M Molokhia, H Takikawa, ...
Clinical Pharmacology & Therapeutics 89 (6), 806-815, 2011
11932011
Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease
AC Mackey, L Green, L Liang, P Dinndorf, M Avigan
Journal of pediatric gastroenterology and nutrition 44 (2), 265-267, 2007
5512007
A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif.
R Duncan, L Bazar, G Michelotti, T Tomonaga, H Krutzsch, M Avigan, ...
Genes & development 8 (4), 465-480, 1994
4031994
Specific binding of heterogeneous ribonucleoprotein particle protein K to the human c-myc promoter, in vitro.
M Takimoto, T Tomonaga, M Matunis, M Avigan, H Krutzsch, G Dreyfuss, ...
Journal of Biological Chemistry 268 (24), 18249-18258, 1993
2991993
High-resolution chromoendoscopy for the diagnosis of diminutive colon polyps: implications for colon cancer screening
AM Axelrad, DE Fleischer, AJ Geller, CC Nguyen, JH Lewis, FH Al-Kawas, ...
GASTROENTEROLOGY-BALTIMORE THEN PHILADELPHIA- 110, 1253-1258, 1996
2231996
Hepatotoxicity of immune checkpoint inhibitors: an evolving picture of risk associated with a vital class of immunotherapy agents
DL Suzman, L Pelosof, A Rosenberg, MI Avigan
Liver International 38 (6), 976-987, 2018
2142018
Randomized trial of chlorambucil for primary biliary cirrhosis
JH Hoofnagle, GL Davis, DF Schafer, M Peters, MI Avigan, SC Pappas, ...
Gastroenterology 91 (6), 1327-1334, 1986
1721986
Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients
N Kothary, IL Diak, A Brinker, S Bezabeh, M Avigan, G Dal Pan
Journal of the American Academy of Dermatology 65 (3), 546-551, 2011
1712011
Delivery of c-myc Antisense Phosphorothioate Oligodeoxynucleotides to Hematopoietic Cells in Culture by Liposome Fusion: Specific Reduction in c-myc Protein …
SL Loke, C Stein, X Zhang, M Avigan, J Cohen, LM Neckers
Mechanisms in B-Cell Neoplasia 1988: Workshop at the National Cancer …, 1988
1691988
A short course of prednisolone in chronic type B hepatitis: report of a randomized, double-blind, placebo-controlled trial
JAYH HOOFNAGLE, GL DAVIS, SC PAPPAS, RG HANSON, M PETERS, ...
Annals of internal medicine 104 (1), 12-17, 1986
1691986
Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: update
AC Mackey, L Green, C Leptak, M Avigan
Journal of pediatric gastroenterology and nutrition 48 (3), 386-388, 2009
1542009
A far upstream element stimulates c-myc expression in undifferentiated leukemia cells.
MI Avigan, B Strober, D Levens
Journal of Biological Chemistry 265 (30), 18538-18545, 1990
1521990
Using controlled clinical trials to learn more about acute drug‐induced liver injury
PB Watkins, PJ Seligman, JS Pears, MI Avigan, JR Senior
Hepatology 48 (5), 1680-1689, 2008
1422008
Scientific and regulatory perspectives in herbal and dietary supplement associated hepatotoxicity in the United States
MI Avigan, RP Mozersky, LB Seeff
International journal of molecular sciences 17 (3), 331, 2016
1272016
Telithromycin‐associated hepatotoxicity: clinical spectrum and causality assessment of 42 cases
AD Brinker, RT Wassel, J Lyndly, J Serrano, M Avigan, WM Lee, LB Seeff
Hepatology 49 (1), 250-257, 2009
1212009
Brief communication: characteristics of spontaneous cases of tuberculosis associated with infliximab
A Raval, G Akhavan-Toyserkani, A Brinker, M Avigan
Annals of Internal Medicine 147 (10), 699-702, 2007
1062007
Studies on the compartmentation of lipid in adipose cells. II. Cholesterol accumulation and distribution in adipose tissue components
J Farkas, A Angel, MI Avigan
Journal of lipid research 14 (3), 344-356, 1973
951973
Clinically significant liver injury in patients treated with natalizumab
S Bezabeh, CM Flowers, C Kortepeter, M Avigan
Alimentary pharmacology & therapeutics 31 (9), 1028-1035, 2010
882010
Targeted Melting and Binding of a DNA Regulatory Element by a Transactivator of c-myc (∗)
L Bazar, D Meighen, V Harris, R Duncan, D Levens, M Avigan
Journal of Biological Chemistry 270 (14), 8241-8248, 1995
741995
Treatment of chronic delta hepatitis with recombinant human alpha interferon
J Hoofnagle, K Mullen, M Peters, M Avigan, Y Park, J Waggoner, J Gerin, ...
Progress in clinical and biological research 234, 291-298, 1987
701987
The system can't perform the operation now. Try again later.
Articles 1–20